TY - JOUR
T1 - DEAR1, a novel tumor suppressor that regulates cell polarity and epithelial plasticity
AU - Chen, Nanyue
AU - Balasenthil, Seetharaman
AU - Reuther, Jacquelyn
AU - Killary, Ann Mc Neill
N1 - Publisher Copyright:
© 2014 American Association for Cancer Research.
PY - 2014/10/15
Y1 - 2014/10/15
N2 - Elucidation of the regulatory controls on epithelial plasticity is pivotal not only to better understand the nature of metastasis but also for the design of targeted therapies to prevent the earliest steps in migration and invasion from the primary tumor. This review will highlight the role of the novel TRIM protein DEAR1 (annotated as TRIM62) in the regulation of apical-basal polarity and acinar morphogenesis as well as its function as a chromosome 1p35 tumor suppressor and negative regulator of TGFβ-driven epithelial-mesenchymal transition (EMT). DEAR1 binds to and promotes the ubiquitination of SMAD3, the major effector of TGFβ-mediated EMT, as well as downregulates SMAD3 targets SNAIL1/2, master transcriptional regulators of EMT. Cumulative results suggest a novel paradigm for DEAR1 in the regulation of the breast tumor microenvironment, polarity, and EMT. Because DEAR1 undergoes loss-of-function mutations, homozygous deletion, as well as copy-number losses in multiple epithelial cancers, including breast cancer, DEAR1 has clinical use as a predictive and prognostic biomarker as well as for stratifying breast cancers and potentially other epithelial tumor types for targeted therapies aimed at the pathways regulated by DEAR1.
AB - Elucidation of the regulatory controls on epithelial plasticity is pivotal not only to better understand the nature of metastasis but also for the design of targeted therapies to prevent the earliest steps in migration and invasion from the primary tumor. This review will highlight the role of the novel TRIM protein DEAR1 (annotated as TRIM62) in the regulation of apical-basal polarity and acinar morphogenesis as well as its function as a chromosome 1p35 tumor suppressor and negative regulator of TGFβ-driven epithelial-mesenchymal transition (EMT). DEAR1 binds to and promotes the ubiquitination of SMAD3, the major effector of TGFβ-mediated EMT, as well as downregulates SMAD3 targets SNAIL1/2, master transcriptional regulators of EMT. Cumulative results suggest a novel paradigm for DEAR1 in the regulation of the breast tumor microenvironment, polarity, and EMT. Because DEAR1 undergoes loss-of-function mutations, homozygous deletion, as well as copy-number losses in multiple epithelial cancers, including breast cancer, DEAR1 has clinical use as a predictive and prognostic biomarker as well as for stratifying breast cancers and potentially other epithelial tumor types for targeted therapies aimed at the pathways regulated by DEAR1.
UR - http://www.scopus.com/inward/record.url?scp=84908116800&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84908116800&partnerID=8YFLogxK
U2 - 10.1158/0008-5472.CAN-14-1171
DO - 10.1158/0008-5472.CAN-14-1171
M3 - Review article
C2 - 25261235
AN - SCOPUS:84908116800
SN - 0008-5472
VL - 74
SP - 5683
EP - 5689
JO - Cancer Research
JF - Cancer Research
IS - 20
ER -